Business Context and Reporting Period
This Form 8-K is a current report filed by Oscar Health, Inc. on March 3, 2025. The filing serves as a Regulation FD disclosure regarding the Company's scheduled participation in the 2025 Raymond James Institutional Investors Conference on the same date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding an upcoming investor presentation rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the Company's intent to reaffirm previously issued guidance.
Guidance, Outlook, and Risks
- Guidance Reaffirmation: Management will reaffirm the full-year 2025 guidance originally provided in the fourth-quarter 2024 financial results press release dated February 4, 2025.
- Forward-Looking Statements: The filing includes standard cautionary language noting that forward-looking statements are subject to risks, assumptions, and uncertainties that could cause actual results to differ materially.
- Risk Factors: Investors are directed to the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, for a detailed list of potential risks.
Investor Verification Checklist
- Verify the specific full-year 2025 guidance figures in the February 4, 2025, press release referenced in this filing.
- Review the "Risk Factors" in the 2024 Form 10-K to understand potential variables affecting the reaffirmed guidance.
- Confirm the date and details of the 2025 Raymond James Institutional Investors Conference for potential live updates.